Urbana, ILNCT05484973Now EnrollingIRB Ready

Alopecia Clinical Trial in Urbana, IL

Access cutting-edge alopecia treatment through this clinical trial at a research site in Urbana. Study-provided care at no cost to qualified participants.

Sponsored by Cooler Heads Care Inc.

Quick Self-Assessment

See if you qualify for this Urbana location

Preparing your pre-screening questions…

Expert Care in Urbana

Access alopecia specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related alopecia treatment provided free

Apply for This Urbana Location

Check if you qualify for this alopecia clinical trial in Urbana, IL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Urbana

    Convenient for IL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Urbana site if eligible
  4. 4Begin participation

About This Alopecia Study in Urbana

The purpose of this prospective study is to assess the ability of AMMA to prevent hair loss in women receiving chemotherapy (CT) for early-stage breast cancer. Additionally, the purpose is also to assess the safety, tolerability and compliance, quality of life, and satisfaction with hair preservation after CT treatment.

Sponsor: Cooler Heads Care Inc.

Who Can Participate

Inclusion Criteria

Female patients ≥ 21 years of age
Documented diagnosis of breast cancer, stage I, II, or III
A planned taxane-containing CT regimen in the adjuvant or neoadjuvant setting with curative intent
Concomitant agents may include trastuzumab, pertuzumab, or other CT agents such as cyclophosphamide, or carboplatin Note: Targeted and/or hormonal therapies intended for use after completion of the taxane-containing CT regimen will not be considered part of the study treatment period, and the AMMA PSCS will not be used during the post-CT targeted and/or hormonal therapy period
Plan to complete the current CT regimen within six months
At least two years out from the last CT causing hair loss with complete recovery of hair
Karnofsky17 performance status 80% or greater
Willing and able to sign informed consent for this study
Willing and able to complete all required study procedures

Exclusion Criteria

Patients with female pattern baldness resembling picture I-3 or higher on the Savin scale
Autoimmune disease affecting hair; e.g. alopecia areata, systemic lupus with associated hair loss, others
A history of whole brain radiation
Plans to use a CT regimen other than those specified in the inclusion criteria; specifically, a regimen not including paclitaxel or docetaxel or a regimen including an anthracycline (AC/T, EC/T, TAC, etc.)
Hormone therapy concurrent with CT. Hormone therapy after CT is permitted
Current and/or prior use of hair growth products, such as Nutrafol, minoxidil, and Keranique
A serious concurrent infection or medical illness which would jeopardize the ability of the patient to complete the planned therapy and follow-up
History of persistent grade 2 (or higher) alopecia induced by prior chemotherapeutic regimens
History of and/or current exposure to other agents, drugs, device, or procedure that may cause hair loss
Cold sensitivity
Intercurrent life-threatening malignancy
Evidence of untreated or poorly controlled hyperthyroidism or hypothyroidism
History or current diagnosis of any of the following: Cold agglutinin disease, cryoglobulinemia, or cryofibrinogenemia
Concurrent hematologic malignancy
Participation in any other clinical investigation
Concurrent treatment with any investigational agent
Any reason the investigator does not believe the patient is a good candidate for the study

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Urbana?

Yes, this clinical trial (NCT05484973) has an active research site in Urbana, IL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Alopecia Treatment Options in Urbana, IL

If you're searching for alopecia treatment options in Urbana, IL, this clinical trial (NCT05484973) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Urbana research site is actively enrolling participants for this clinical trial. You'll receive care from experienced alopecia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all alopecia clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Urbana, IL

See all pulmonary embolism clinical trials recruiting in Urbana — not just this study.

Browse Pulmonary Embolism Trials in Urbana →

Browse More Trials by Condition

Pulmonary Embolism TrialsAlopecia TrialsAll Conditions →

Ready to Join in Urbana?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Urbana, IL